Cole Cole TA TA Zhao Zhao H H Collier Collier TJ TJ α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease JCI Insight JCI Insight 2021 2021 6 6 5 5 e135633 e135633 10.1172/jci.insight.135633 10.1172/jci.insight.135633. Here, SNCA is linked to Parkinson disease.